The global 3D
cell culture market size is expected to reach USD 1.69 billion by
2024, according to a new report by Grand View Research, Inc., exhibiting a
14.8% CAGR during the forecast period. Need to incorporate 3D cell culture
systems in research for better representation of in vivo environment
has driven development of new materials and methods, thereby propelling market
growth.
3D cell culture is more suitable for in vivo modeling
due to the resemblance they provide to morphology of organ or cells. Several 3D
cell culture options are available in the form of scaffold-based,
scaffold-free, and 3D bioreactor systems. Emergence of 3D optimized assays,
kits, and protocols, along with maturity in development of different assay
techniques, is projected to accelerate market growth.
Increasing adoption of tissue engineering and organ
transplantation for chronic diseases is projected to drive adoption in research
over the forecast period. Furthermore, use of microchips to implement culturing
through use of micro-fabricated tissue component is expected to present the
market with potential avenues.
Fabrication techniques to produce scaffold-free
systems that are inexpensive, transparent, and compatible with liquid handling
tools have emerged. Rapid adoption of these systems for tissue engineering research,
drug discovery, and personalized medicine contributes to market growth.
Scaffold-free technology is expected to observe the fastest growth over the
next few years, registering an estimated CAGR of around 15.7% from 2016 to
2024.
Browse full research report on 3D Cell Culture Market: https://www.grandviewresearch.com/industry-analysis/3d-cell-culture-market
Further
key findings from the report suggest:
- Emergence of novel fabrication techniques contributes to the growth
of scaffold-free 3D cell culture systems
- Rapid adoption of culturing systems in cancer research for
development of immortalized established cell lines or primary cell
cultures to perform in vivo drug screening has led to its largest revenue
share
- 3D bioprinting enables creation of 3D printed building blocks of
embryonic stem cells, which could be further used for micro-organ
generation and tissue regeneration experiments
- Changing of regulatory policies for stem cell research and high
potential of 3D culturing tools fuels the stem cell research segment
- North America dominated the global 3D cell culture market with a
share of over 41.0% in 2016. Presence of major pharma and biotech players
that collaborate with research laboratories to implement these
technologies drives progress in U.S.
- Asia Pacific is projected to witness substantial growth over the
forecast period owing to rapid developments across major economies,
especially in the tissue engineering and stem cell research domain. APAC
is expected to exhibit a CAGR of 16% during the forecast period
- Key players include Merck, 3D Biotek LLC; 3D Biomatrix; Nano3D
Biosciences Corning Inc.; VWR International, LLC; Thermo Fisher
Scientific; Global Cell Solutions, Inc.; Becton Dickinson and Company;
Tecan; InSphero AG; and Lonza Group
- Major players focus on collaborating with laboratories to
commercialize technologies that are not potentially established in the
market space.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/healthcare
Grand
View Research has segmented the global 3D cell culture market on the basis of
technology, application, end use, culture component, and region:
3D
Cell Culture Technology Outlook (Revenue, USD Million, 2013 - 2024)
- Scaffold
based
- Hydrogels
- Polymeric
scaffolds
- Micropatterned
Surface Microplates
- Scaffold free
- Hanging drop
microplates
- Spheroid
microplates containing Ultra-Low Attachment (ULA) coating
- Microfluidic
3D cell culture
- Magnetic
levitations & 3D bioprinting
- 3D
Bioreactors
3D
Cell Culture Application Outlook (Revenue, USD Million, 2013 - 2024)
- Cancer
- Tissue
engineering & Immunohistochemistry
- Drug
development
- Stem cell
research
- Others
3D
Cell Culture End-use Outlook (Revenue, USD Million, 2013 - 2024)
- Biotechnology
and pharmaceutical industries
- Research
laboratories and institutes
- Hospitals and
diagnostic centers
- Others
3D
Cell Culture Component Outlook (Revenue, USD Million, 2013 - 2024)
- Media
- Reagents and
Consumables
3D
Cell Culture Regional Outlook (Revenue, USD Million, 2013 - 2024)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Middle East
& Africa
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment